⌘K

Login Start Free

Home/Filings/4/0000810084-10-000004

4//SEC Filing

Makar Ralph 4

Accession 0000810084-10-000004

CIK 0000810084other

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 7:03 PM ET

Size

8.3 KB

Accession

0000810084-10-000004

Insider Transaction Report

Form 4

Period: 2010-01-30

BIOJECT MEDICAL TECHNOLOGIES INCBJCT

CEO/President

Transactions

Exercise/Conversion
BJCT Common Stock
2010-01-30+50,000→ 394,034 total
Exercise/Conversion
Restricted Stock Unit
2010-01-30−50,000→ 307,601 total
From: 2010-01-30→ BJCT Common Stock (50,000 underlying)

Holdings

BJCT Common Stock
(indirect: By 401(k))
86,916

Footnotes (4)

[F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
[F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
[F3]No expiration date.
[F4]Includes Series F Preferred Stock 67.600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 83,334.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeother

Related Parties

1

filerCIK 0001414579

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 7:03 PM ET
Size: 8.3 KB

View on SEC.gov